Navigation Links
Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine
Date:9/8/2009

BEIJING, Sept. 8 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of vaccines in China, today announced that the first lot of PANFLU.1, its H1N1 vaccine, has passed the lot release process of China's National Institute for the Control of Pharmaceutical and Biological Products and obtained the Certificate for the Release of Biological Products, which means the released vaccines are ready for delivery.

The released vaccine will be supplied to the Beijing CDC and China's central government. Sinovac has previously announced an order of five million doses with the minimum purchase quantity of two million doses from the Beijing CDC and 3.3 million doses from the central government, all of which is to be delivered by the end of September.

Mr. Weidong Yin, Chairman, President and CEO, commented, "We are proud to be at the forefront of the fight against the H1N1 virus. With these shipments, we can, along with the government and our fellow companies, begin the fight in earnest to control the spread of H1N1."

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's commercialized vaccines include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), Anflu(R) (influenza) and Panflu(TM) (H5N1). Sinovac is currently developing a Universal Pandemic Influenza vaccine and a Japanese encephalitis vaccine. Additional information about Sinovac is available on its website, http://www.sinovac.com . To be added to our distribution list, please email:

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sinovac Announces Postponement of Annual General Meeting
2. Sinovac Requests Extension for Annual Shareholders Meeting
3. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
4. Sinovac Closes $9.75 Million Private Placement
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. Sinovac Announces Adjournment of Annual General Meeting
7. Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2007 Financial Results
8. Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results
9. Sinovac Biotech Holds Annual General Meeting
10. Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008
11. Sinovac Receives RMB 20 Million Purchase Order for Healive from Chinas Ministry of Health to Vaccinate Earthquake Victims

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...hanghaiBiolaxyannouncedthe,ChineseStateFood&Dr...alnewdrugapplication(IND)foritsoralinsulinproject,...etes.ThisIND,approvalallowsBiolaxytoinitiateitsfir...haracteristicofhighbloodglucoseandpoor,metabolism....-and,macro-vasculardiseases,lossofvision,kidneyfai...
(Date:11/24/2009)...all/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobals...atithassubmittedaMAAtotheEuropeanMedicinesAgencyfo...herapyindevelopment,forthetreatmentofType1Gaucherd...lucerasealfathathasbeensubmitted,withprevious,subm...globalsupplyshortageofthecurrentlyapprovedandmarke...
(Date:11/24/2009)...s Service (CAS), the global expert on chemical inf...w the world,s leading producer of patent invention...patent office, the World Intellectual Property Org... Trademark Office (USPTO) for more than a decade, ...ceeded Japan for the first time on a monthly basis...
(Date:11/23/2009)...rbon layer in which the carbon atoms are arranged ...rbon nanotubes are rolled-up sheets of graphene, a...raphene boasts some very special characteristics ...al conductor, and reconciles such conflicting qual...raphene is impermeable to gases, which makes it in...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Polymer with honeycomb structure 2
...K, Calif., Feb. 24 Novasys Medical, Inc., a devel...nounced today that Noridian,Administrative Service...benefits in nine states, is now covering the non-s...inary incontinence (SUI). Noridian currently,admi...are beneficiaries in,Alaska, Arizona, Montana, Nor...
...OTTE, N.C., Feb. 24 The Charlotte-Mecklenburg reg... economic issues. In,Mecklenburg County, the NC F...nd for services in over 10 years. Sally Gilbert, ...llness event, the Charlotte Anti-Aging Expo &,... "We can all have a vibrant and healthy lifestyle....
... Feb. 24 Mindset BioPharmaceuticals (USA) Inc ("M...nd other shareholders announced today that it has ...o patent applications describing the use of insuli...t of memory loss. Drugs of this type include Rosig... for the treatment of type II diabetes mellitus. ...
Other Biology Technology:Noridian Medicare Now Covers Renessa(R) Treatment for Incontinence in Women 2Charlotte Anti-Aging Expo & Symposium Supports Free Clinics 2Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss 2Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss 3
(Date:11/23/2009)...The National Institute of General Medical Sciences...h (NIH), is investing $42.3 million for grants in ...ties (GO)." NIH developed the GO grant program to ...g funds provided by the American Recovery and Rein...nd projects that promise to have a significant imp...
(Date:11/23/2009)... A new study from Perth,s Telethon Institute for ...amount and timing of alcohol consumption in pregna... The study has just been published online in the i...Colleen O,Leary said the analysis was drawn from a...eted a questionnaire three months after the baby,s...
(Date:11/23/2009)...Carlos Mara Romeo Casabona is Director of the Inte...nome at Deusto University and the University of th...e up of jurists but also has other experts such as...edicine and even specialists in ethics. , The In...Genome at the Universities of Deusto and the Basqu...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3New study links alcohol in pregnancy to child behavior problems 2Research and legislation should go hand in hand, as much as possible 2Pharmasset to Present at Canaccord Adams Conference 13394 1Pharmasset to Present at Canaccord Adams Conference 13394 2Pharmasset to Present at Canaccord Adams Conference 13394 3Autism May Hinder Ability to Read Body Language 53773 1Autism May Hinder Ability to Read Body Language 53773 22009 American Association of Pharmaceutical Scientists Annual Meeting and Exposition 53770 1
...People around the world will soon have access to a...ual exploration of the cardiovascular system creat...rt medical imaging and computer-generate animation...nder Tsiaras, Anatomical Travelogue, will allow us...etwork of arteries and veins and as it becomes inf...
...N ARBOR, Mich.---University of Michigan researcher...gerprints" in coal to track down sources of mercur...ublished in today,s online issue of the journal E...a naturally occurring element, but some 2000 tons ...enerated sources such as incinerators, chlorine-pr...
...oteins found in sperm are central to understanding...ew diagnostic methods and fertility treatments acc...lar and Cellular Proteomics (MCP). The article de...focusing on the function of proteins in a cell, ca...identify which proteins in sperm cells are dysfunc...
Other Biology News:TheVisualMD.com launches new animated 3-D views of human body in action 2'Fingerprinting' method tracks mercury emissions from coal 2'Fingerprinting' method tracks mercury emissions from coal 3Proteins in sperm unlock understanding of male infertility says new study 2
... Antigen Design , Customer Peptide Synthesis , 2...bove 90% , 20 mg will return to customer for fut... Rabbits x 2 , Maintenance 102 days/each , ... injections x5 /each , Test bleed (app. 5 ml) ...
...t Contains the following: , Coated Capture Antib..., Wash/Sample Diluent: 300 mL of 2X concentrate ,...yophilized peptide , Lyophilized Standard Diluen...ncentrate , Secondary Antibody-HRP: 30 microL of...
THP-1 Cell Slide from ProSci, Inc
Acrylamide/Bis 19:1 40% (w/v) solution from Ambion
Biology Products: